Amy Kennedy, Ph.D., M.P.H.
Presidential Management Fellow, Office of the Associate Director
- Telephone: (240) 276-6723
- Fax: (240) 276-7921
- E-mail: firstname.lastname@example.org
Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
National Institutes of Health
9609 Medical Center Drive, Rm. 4E114, MSC 9763
Bethesda, MD 20892
(For express delivery, use Rockville, MD 20850)
- Integrative epidemiology
- Cancer/health disparities
- Immunologic factors influencing susceptibility to cancer
- Risk factors for second cancers
- Implementation science
- Design and utilization of cohort studies
- Risk factors for childhood cancer and understanding long-term health outcomes
- Genetic susceptibility to cancer
- Ph.D. – Public Health, specialization in Epidemiology
Florida International University
- M.P.H. – Environmental and Occupational Health
Florida International University
- B.S. – Biology
University of Miami
Dr. Amy Kennedy is a Presidential Management Fellow (PMF) in the Epidemiology and Genomics Research Program's (EGRP) Office of the Associate Director. As a PMF, Dr. Kennedy will complete several rotations in various offices within the Division of Cancer Control and Population Sciences (DCCPS), including EGRP. Dr. Kennedy's assignments will involve novel cancer control research projects that aim to reduce risk, incidence, and deaths from cancer as well as enhance the quality of life for cancer survivors.
Dr. Kennedy joined NCI in 2014 as a Cancer Research Training Award (CRTA) Fellow with EGRP's Cohorts and Consortia Team. Her responsibilities included assisting in managing national and international cancer epidemiology cohorts and consortia, supporting the Genetic Associations and Mechanisms in Oncology (GAME-ON) initiative, as well as analyzing data and preparing manuscripts.
Before joining EGRP, Dr. Kennedy completed her Ph.D. in Public Health, specializing in Epidemiology. For her doctoral dissertation, she investigated correlations among genetic polymorphisms, birth characteristics, and the risk of childhood acute lymphoblastic leukemia. Prior to her Ph.D., Dr. Kennedy received her M.P.H. from FIU's Department of Environmental and Occupational Health. She completed her Master's Supervised Field Experience at the Miller School of Medicine at the University of Miami, where her project focused on the effects of the built environment on children's health and safety, and included a program proposal to decrease pedestrian injuries and childhood obesity by promoting walking to and from school. Her undergraduate studies were conducted at the University of Miami (BS in Biology).
Kennedy AE, Kamdar KY, Lupo PJ, Okcu MF, Scheurer ME, & Dorak MT. Birth Characteristics and Childhood Leukemia Risk: Correlations with Genetic Markers. J Pediatr Hematol Oncol. 2015 Jul; 3(5):e301-7.
Kennedy AE, Kamdar KY, Lupo PJ, Okcu MF, Scheurer ME, Baum MK, & Dorak MT. Examination of HFE associations with childhood leukemia risk and extension to other iron regulatory genes. Leuk Res. 2014 Sep; 38(9):1055-60.
Kennedy AE, Kamdar KY, Lupo PJ, Okcu MF, Scheurer ME, & Dorak MT. Genetic Markers in a Multiethnic Sample for Childhood Acute Lymphoblastic Leukemia Risk. Leuk Lymphoma. 2014 Jun; 16:1-6.
Kennedy AE, Singh S, Dorak MT. Re: Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein–Barr Virus Status–Defined Subgroups. J Natl Cancer Inst. 2012 Jun 6; 104(11): 884-885.
Felty Q, Yoo C, Kennedy A. Gene expression profile of endothelial cells exposed to estrogenic environmental compounds: implications to pulmonary vascular lesions. Life Sci. 2010 Jun 19; 86(25-26): 919-927.
Hotz G, Kennedy A, Lutfi K, Cohn SM. Preventing pediatric pedestrian injuries. J Trauma. 2009 May; 66(5): 1492-1499.
Hotz G, de Marcilla A. G, Lutfi K, Kennedy A, Castellon P, & Duncan R. The WalkSafe Program: developing and evaluating the educational component. J Trauma. 2009 March; 66(3 Suppl), S3-9.